Literature DB >> 2239154

Expression of monoamine oxidase B activity in astrocytes of senile plaques.

S Nakamura1, T Kawamata, I Akiguchi, M Kameyama, N Nakamura, H Kimura.   

Abstract

Monoamine oxidase (MAO) histochemistry has been performed in brains from patients with dementia of Alzheimer type (DAT) and aged controls. Conspicuous MAO-positive cell clusters were frequently observed in the amygdala, hippocampus, and insular cortex in the brains of DAT. Double staining with glial fibrillary acidic protein immunohistochemistry revealed that the cluster-forming MAO-positive cells were astrocytes. Using Bielschowsky's method, Congo red and thioflavin S counterstaining, this astrocytic mass was shown to be associated with senile plaques. By the enzyme inhibition experiment, MAO activity in senile plaques was revealed to be of type B. The present results clearly indicate that MAO-B activity is expressed in fibrillary astrocytes in or around senile plaques, suggesting that these astrocytes metabolize exogenous amines in senile plaques.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2239154     DOI: 10.1007/bf00307697

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  30 in total

1.  Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

Authors:  J S Fowler; R R MacGregor; A P Wolf; C D Arnett; S L Dewey; D Schlyer; D Christman; J Logan; M Smith; H Sachs
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

2.  Dopamine in Alzheimer's disease and senile dementia.

Authors:  C M Yates; Y Allison; J Simpson; A F Maloney; A Gordon
Journal:  Lancet       Date:  1979-10-20       Impact factor: 79.321

3.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

4.  Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem.

Authors:  C Konradi; E Svoma; K Jellinger; P Riederer; R Denney; J Thibault
Journal:  Neuroscience       Date:  1988-09       Impact factor: 3.590

5.  Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls.

Authors:  J J Mann; M Stanley
Journal:  Acta Psychiatr Scand       Date:  1984-02       Impact factor: 6.392

6.  Monoamine oxidase-containing neurons in the cat hypothalamus: distribution and ascending projection to the cerebral cortex.

Authors:  K Kitahama; K Sakai; H Tago; H Kimura; T Maeda; M Jouvet
Journal:  Brain Res       Date:  1984-12-17       Impact factor: 3.252

7.  On the mode of action of L-deprenyl in the human central nervous system.

Authors:  P Riederer; M B Youdim; W D Rausch; W Birkmayer; K Jellinger; D Seemann
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

8.  Localization of MAO-A and MAO-B in human brain: a step in understanding the therapeutic action of L-deprenyl.

Authors:  P Riederer; C Konradi; V Schay; E Kienzl; G Birkmayer; W Danielczyk; E Sofic; M B Youdim
Journal:  Adv Neurol       Date:  1987

9.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

Authors:  K Chiba; A Trevor; N Castagnoli
Journal:  Biochem Biophys Res Commun       Date:  1984-04-30       Impact factor: 3.575

10.  Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques.

Authors:  R Katzman; R Terry; R DeTeresa; T Brown; P Davies; P Fuld; X Renbing; A Peck
Journal:  Ann Neurol       Date:  1988-02       Impact factor: 10.422

View more
  37 in total

1.  Immunohistochemical localization of the proteinase inhibitor region of amyloid precursor proteins in the neocortex of Alzheimer's disease and aged controls.

Authors:  S Nakamura; T Suenaga; I Akiguchi; J Kimura; S Nakamura; Y Tokushima; N Kitaguchi; Y Takahashi; S Shiojiri
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography.

Authors:  S M Aquilonius; S S Jossan; J G Ekblom; H Askmark; P G Gillberg
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 3.  Type A and B monoamine oxidases distinctly modulate signal transduction pathway and gene expression to regulate brain function and survival of neurons.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-12-26       Impact factor: 3.575

4.  MAO-B Inhibitors Do Not Block In Vivo Flortaucipir([18F]-AV-1451) Binding.

Authors:  Allan K Hansen; David J Brooks; Per Borghammer
Journal:  Mol Imaging Biol       Date:  2018-06       Impact factor: 3.488

Review 5.  Imaging Translocator Protein as a Biomarker of Neuroinflammation in Dementia.

Authors:  William C Kreisl; Ioline D Henter; Robert B Innis
Journal:  Adv Pharmacol       Date:  2017-11-10

6.  Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis.

Authors:  Paul D Piehowski; Vladislav A Petyuk; Daniel J Orton; Fang Xie; Ronald J Moore; Manuel Ramirez-Restrepo; Anzhelika Engel; Andrew P Lieberman; Roger L Albin; David G Camp; Richard D Smith; Amanda J Myers
Journal:  J Proteome Res       Date:  2013-04-10       Impact factor: 4.466

Review 7.  Perspectives on MAO-B in aging and neurological disease: where do we go from here?

Authors:  M Jyothi Kumar; Julie K Andersen
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

8.  CSF Biomarkers for Alzheimer's Disease Diagnosis.

Authors:  A Anoop; Pradeep K Singh; Reeba S Jacob; Samir K Maji
Journal:  Int J Alzheimers Dis       Date:  2010-06-23

9.  Early anti-oxidative and anti-proliferative curcumin effects on neuroglioma cells suggest therapeutic targets.

Authors:  Heena D Panchal; Karen Vranizan; Chun Y Lee; Jacqueline Ho; John Ngai; Paola S Timiras
Journal:  Neurochem Res       Date:  2008-02-26       Impact factor: 3.996

Review 10.  Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond.

Authors:  Hristelina Ilieva; Magdalini Polymenidou; Don W Cleveland
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.